Cost-effectiveness of umeclidinium/vilanterol versus aclidinium monotherapy for symptomatic COPD in Colombia: a lifetime Markov model
Year: 2026
Type: article
Author: Jefferson Antonio Buendía
Institution: Universidad de Antioquia
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7236021693
